These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8809860)

  • 1. Cocaine withdrawal alters regulatory elements of dopamine neurons.
    Pilotte NS; Sharpe LG
    NIDA Res Monogr; 1996; 163():193-202. PubMed ID: 8809860
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal.
    Bowers MB; Malison RT; Seibyl JP; Kosten TR
    Biol Psychiatry; 1998 Feb; 43(4):278-81. PubMed ID: 9513737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine withdrawal reduces dopamine transporter binding in the shell of the nucleus accumbens.
    Pilotte NS; Sharpe LG; Rountree SD; Kuhar MJ
    Synapse; 1996 Jan; 22(1):87-92. PubMed ID: 8822482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of dopamine transporter mRNA in the rat brain: mapping, effects of "binge" cocaine administration and withdrawal.
    Maggos CE; Spangler R; Zhou Y; Schlussman SD; Ho A; Kreek MJ
    Synapse; 1997 May; 26(1):55-61. PubMed ID: 9097405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine abuse: hard knocks for the dopamine hypothesis?
    Caine SB
    Nat Neurosci; 1998 Jun; 1(2):90-2. PubMed ID: 10195118
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons.
    Hinerth MA; Collins HA; Baniecki M; Hanson RN; Waszczak BL
    Synapse; 2000 Dec; 38(3):305-12. PubMed ID: 11020233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3 alpha-(4'-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters: novel ligands with high affinity and selectivity at the dopamine transporter.
    Holmquist CR; Keverline-Frantz KI; Abraham P; Boja JW; Kuhar MJ; Carroll FI
    J Med Chem; 1996 Oct; 39(21):4139-41. PubMed ID: 8863789
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurobiology. Dopamine's reversal of fortune.
    Blakely RD
    Science; 2001 Sep; 293(5539):2407-9. PubMed ID: 11577225
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional differences in rat brain dopamine transporter binding: function of time after chronic cocaine.
    Hitri A; Wyatt RJ
    Clin Neuropharmacol; 1993 Dec; 16(6):525-39. PubMed ID: 9377588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
    Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
    Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons.
    Ingram SL; Prasad BM; Amara SG
    Nat Neurosci; 2002 Oct; 5(10):971-8. PubMed ID: 12352983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine.
    Woolverton WL; Wang Z
    Eur J Pharmacol; 2004 Feb; 486(3):251-7. PubMed ID: 14985046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective regulation of dopamine transporter binding in the shell of the nucleus accumbens by adrenalectomy and corticosterone-replacement.
    Sarnyai Z; McKittrick CR; McEwen BS; Kreek MJ
    Synapse; 1998 Nov; 30(3):334-7. PubMed ID: 9776137
    [No Abstract]   [Full Text] [Related]  

  • 14. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of rat dopamine transporter mRNA: effects of cocaine treatment and withdrawal.
    Xia Y; Goebel DJ; Kapatos G; Bannon MJ
    J Neurochem; 1992 Sep; 59(3):1179-82. PubMed ID: 1494906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.
    Ghorai SK; Cook C; Davis M; Venkataraman SK; George C; Beardsley PM; Reith ME; Dutta AK
    J Med Chem; 2003 Mar; 46(7):1220-8. PubMed ID: 12646032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TROTEC-1: a new high-affinity ligand for labeling of the dopamine transporter.
    Hoepping A; Reisgys M; Brust P; Seifert S; Spies H; Alberto R; Johannsen B
    J Med Chem; 1998 Nov; 41(23):4429-32. PubMed ID: 9804682
    [No Abstract]   [Full Text] [Related]  

  • 18. The striatal transporter for dopamine in the rat may be kinetically up-regulated following 3 weeks of withdrawal from cocaine self-administration.
    Meiergerd SM; Hooks SM; Schenk JO
    J Neurochem; 1994 Oct; 63(4):1277-81. PubMed ID: 7931279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug abuse and mental illness: progress in understanding comorbidity.
    Volkow ND
    Am J Psychiatry; 2001 Aug; 158(8):1181-3. PubMed ID: 11481146
    [No Abstract]   [Full Text] [Related]  

  • 20. Voltage-dependency of the dopamine transporter in rat brain.
    Zahniser NR; Gerhardt GA; Hoffman AF; Lupica CR
    Adv Pharmacol; 1998; 42():195-8. PubMed ID: 9327877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.